Explore more publications!
Essential Healthcare News
Got News to Share?

Essential Healthcare News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on February 20, 2026

Atopic Disease Therapeutics Market Set to Witness Significant Growth by 2026-2033 | Astellas Pharma Inc, Bayer AG
Feb. 20, 2026

Atopic Disease Therapeutics Market Set to Witness Significant Growth by 2026-2033 | Astellas Pharma Inc, Bayer AG

Indeterminate EIN Presswire
Nebivolol Tablets Market Set to Witness Massive Growth by 2033 | AstraZeneca, Novartis, Ranbaxy Laboratories
Feb. 20, 2026

Nebivolol Tablets Market Set to Witness Massive Growth by 2033 | AstraZeneca, Novartis, Ranbaxy Laboratories

Indeterminate EIN Presswire
Cochineal Extract Market Witnessing High Growth | Demand, Size & Regional Analysis 2026-2033 | Diana Food, BASF SE
Feb. 20, 2026

Cochineal Extract Market Witnessing High Growth | Demand, Size & Regional Analysis 2026-2033 | Diana Food, BASF SE

Indeterminate EIN Presswire
Tenovi Launches Next-Generation Cellular-Connected Bariatric Scale for High-Precision Remote Patient Monitoring
Feb. 20, 2026

Tenovi Launches Next-Generation Cellular-Connected Bariatric Scale for High-Precision Remote Patient Monitoring

Indeterminate EIN Presswire
PurpleAI Announces Advisory Engagement with Joshua N. Goldstein, MD, PhD
Feb. 20, 2026

PurpleAI Announces Advisory Engagement with Joshua N. Goldstein, MD, PhD

Indeterminate EIN Presswire
CMTA Appoints David Stark, MD, and Catherine Illingworth to Board of Directors, Expanding Clinical and Biotech Expertise
Feb. 20, 2026

CMTA Appoints David Stark, MD, and Catherine Illingworth to Board of Directors, Expanding Clinical and Biotech Expertise

Indeterminate EIN Presswire
Caffeine Gummies Market Growth Overview, Facts & Figures, Segmentation, Future Trends and Historical Analysis By 2033
Feb. 20, 2026

Caffeine Gummies Market Growth Overview, Facts & Figures, Segmentation, Future Trends and Historical Analysis By 2033

Indeterminate EIN Presswire
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment
Feb. 20, 2026

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment

Indeterminate GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Feb. 20, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
Feb. 20, 2026

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

Indeterminate GlobeNewswire
Polish researchers have shown that photon‑counting CT improves lumen visualization where it matters most
Feb. 20, 2026

Polish researchers have shown that photon‑counting CT improves lumen visualization where it matters most

Indeterminate EIN Presswire
TitanBody Reports Rising Demand for EMS Workout Suits Among Busy Professionals
Feb. 20, 2026

TitanBody Reports Rising Demand for EMS Workout Suits Among Busy Professionals

Indeterminate EIN Presswire
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Feb. 20, 2026

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb. 20, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Feb. 20, 2026

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb. 20, 2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb. 20, 2026

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
Feb. 20, 2026

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

Indeterminate GlobeNewswire
Penta Foundation Announces 2026 Brighter Future Award Winners, Honoring Global Champions of Infectious Disease Equity
Feb. 20, 2026

Penta Foundation Announces 2026 Brighter Future Award Winners, Honoring Global Champions of Infectious Disease Equity

Indeterminate EIN Presswire
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
Feb. 20, 2026

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions